These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy. Howell KL; DeVita RJ; Garcia-Calvo M; Meurer RD; Lisnock J; Bull HG; McMasters DR; McCann ME; Mills SG Bioorg Med Chem Lett; 2010 Dec; 20(23):6929-32. PubMed ID: 21030254 [TBL] [Abstract][Full Text] [Related]
3. Multiple strategies for the preparation of a sulfur-35 labeled NPC1L1 radioligand. Simeone JP; Braun MP; Leone JF; Lin P; DeVita RJ; Garcia-Calvo M; Bull HG; Lisnock J; Dean DC Bioorg Med Chem Lett; 2009 Sep; 19(17):5033-6. PubMed ID: 19631535 [TBL] [Abstract][Full Text] [Related]
4. Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold. Lepifre F; Christmann-Franck S; Roche D; Leriche C; Carniato D; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E Bioorg Med Chem Lett; 2009 Jul; 19(13):3682-5. PubMed ID: 19450980 [TBL] [Abstract][Full Text] [Related]
5. Unconventional 2D shape similarity method affords comparable enrichment as a 3D shape method in virtual screening experiments. Ebalunode JO; Zheng W J Chem Inf Model; 2009 Jun; 49(6):1313-20. PubMed ID: 19480404 [TBL] [Abstract][Full Text] [Related]
6. Similarity searching and scaffold hopping in synthetically accessible combinatorial chemistry spaces. Boehm M; Wu TY; Claussen H; Lemmen C J Med Chem; 2008 Apr; 51(8):2468-80. PubMed ID: 18380426 [TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel protein kinase B inhibitor by structure-based virtual screening. Medina-Franco JL; Giulianotti MA; Yu Y; Shen L; Yao L; Singh N Bioorg Med Chem Lett; 2009 Aug; 19(16):4634-8. PubMed ID: 19604696 [TBL] [Abstract][Full Text] [Related]
8. A virtual screening study of the 18 kDa translocator protein using pharmacophore models combined with 3D-QSAR studies. Tuccinardi T; Taliani S; Bellandi M; Da Settimo F; Da Pozzo E; Martini C; Martinelli A ChemMedChem; 2009 Oct; 4(10):1686-94. PubMed ID: 19688807 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach. Lakshmi PJ; Kumar BV; Nayana RS; Mohan MS; Bolligarla R; Das SK; Bhanu MU; Kondapi AK; Ravikumar M Bioorg Med Chem; 2009 Aug; 17(16):6040-7. PubMed ID: 19631549 [TBL] [Abstract][Full Text] [Related]
10. Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches. Mochalkin I; Miller JR; Narasimhan L; Thanabal V; Erdman P; Cox PB; Prasad JV; Lightle S; Huband MD; Stover CK ACS Chem Biol; 2009 Jun; 4(6):473-83. PubMed ID: 19413326 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel serotonin 2C receptor ligands by sequential virtual screening. Ahmed A; Choo H; Cho YS; Park WK; Pae AN Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901 [TBL] [Abstract][Full Text] [Related]
12. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1. Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055 [TBL] [Abstract][Full Text] [Related]
13. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening. Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I. Furet P; Schoepfer J; Radimerski T; Chène P Bioorg Med Chem Lett; 2009 Aug; 19(15):4014-7. PubMed ID: 19560355 [TBL] [Abstract][Full Text] [Related]
15. Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids. Degliesposti G; Kasam V; Da Costa A; Kang HK; Kim N; Kim DW; Breton V; Kim D; Rastelli G ChemMedChem; 2009 Jul; 4(7):1164-73. PubMed ID: 19437467 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols. Kim CY; Mahaney PE; McConnell O; Zhang Y; Manas E; Ho DM; Deecher DC; Trybulski EJ Bioorg Med Chem Lett; 2009 Sep; 19(17):5029-32. PubMed ID: 19632110 [TBL] [Abstract][Full Text] [Related]
17. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening. Cheeseright TJ; Holm M; Lehmann F; Luik S; Göttert M; Melville JL; Laufer S J Med Chem; 2009 Jul; 52(14):4200-9. PubMed ID: 19489590 [TBL] [Abstract][Full Text] [Related]
18. Potent benzimidazolone-based CGRP receptor antagonists. Theberge CR; Bednar RA; Bell IM; Corcoran HA; Fay JF; Hershey JC; Johnston VK; Kane SA; Mosser S; Salvatore CA; Williams TM; Zartman CB; Zhang XF; Graham SL; Vacca JP Bioorg Med Chem Lett; 2008 Dec; 18(23):6122-5. PubMed ID: 18947992 [TBL] [Abstract][Full Text] [Related]
19. Efficient exploration of large combinatorial chemistry spaces by monomer-based similarity searching. Yu N; Bakken GA J Chem Inf Model; 2009 Apr; 49(4):745-55. PubMed ID: 19309177 [TBL] [Abstract][Full Text] [Related]
20. LigMatch: a multiple structure-based ligand matching method for 3D virtual screening. Kinnings SL; Jackson RM J Chem Inf Model; 2009 Sep; 49(9):2056-66. PubMed ID: 19685924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]